TRUSOPT Drug Patent Profile
✉ Email this page to a colleague
When do Trusopt patents expire, and what generic alternatives are available?
Trusopt is a drug marketed by Msd Sub Merck and is included in one NDA.
The generic ingredient in TRUSOPT is dorzolamide hydrochloride. There are fifteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trusopt
A generic version of TRUSOPT was approved as dorzolamide hydrochloride by HIKMA on October 28th, 2008.
Summary for TRUSOPT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 92 |
Clinical Trials: | 12 |
Patent Applications: | 385 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRUSOPT |
What excipients (inactive ingredients) are in TRUSOPT? | TRUSOPT excipients list |
DailyMed Link: | TRUSOPT at DailyMed |
Recent Clinical Trials for TRUSOPT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Eye Institute (NEI) | Phase 3 |
University of Miami | Phase 3 |
National Eye Institute (NEI) | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for TRUSOPT
Paragraph IV (Patent) Challenges for TRUSOPT
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TRUSOPT | Ophthalmic Solution | dorzolamide hydrochloride | 2% | 020408 | 1 | 2005-10-11 |
US Patents and Regulatory Information for TRUSOPT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msd Sub Merck | TRUSOPT | dorzolamide hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020408-001 | Dec 9, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRUSOPT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Msd Sub Merck | TRUSOPT | dorzolamide hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020408-001 | Dec 9, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Msd Sub Merck | TRUSOPT | dorzolamide hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020408-001 | Dec 9, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRUSOPT
See the table below for patents covering TRUSOPT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 73152 | PROCESS FOR REDUCING INTRA-OCULAR PRESSURE | ⤷ Try a Trial |
Portugal | 87832 | PROCESSO PARA A PREPARACAO DE SULFONAMIDAS AROMATICAS, CONDENSADAS COM UM ANEL HETEROCICLICO, UTEIS COMO AGENTES ANTIGLAUCOMA | ⤷ Try a Trial |
Sweden | 455919 | PREPARAT FOR SENKNING AV OGATS INTRAOKULERA TRYCK INNEHALLANDE SULFONAMID | ⤷ Try a Trial |
Japan | H0245604 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TRUSOPT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0509752 | SPC/GB99/043 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: DORZOLAMIDE OR AN OPHTHALMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY DORZOLAMIDE HYDROCHOLORIDE, PLUS TIMOLOL OR AN OPHTHAMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY TIMOLOL MALEATE; REGISTERED: DK 19045 19980306; UK PL 00025/0373 19980804 |
0509752 | C990041 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DORZOLAMIDE, DESGEWENST IN DE VORM VAN EEN OFTALMOLOGISCH AAN- VAARDBAAR ZOUT, EN TIMOLOL, DESGEWENST IN DE VORM VAN EEN OFTAL -MOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER DORZOLLAMIDEHY- DROCHLORIDE EN TIMOLOLMALEAAT, EEN EN ANDER ZODANIG DAT 0,05; NATL REGISTRATION NO/DATE: VG 22871 19980805; FIRST REGISTRATION: DK 19045 19980306 |
0296879 | 96C0003 | Belgium | ⤷ Try a Trial | PRODUCT NAME: HYDROCHLORIDUM, EQ. DORZOLAMIDUM; NAT. REGISTRATION NO/DATE: 922 IS 168 F13 19951019; FIRST REGISTRATION: SE 12208 19941219 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |